Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01403038
Recruitment Status : Completed
First Posted : July 27, 2011
Last Update Posted : January 8, 2013
Neurocrine Biosciences
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2012
Actual Study Completion Date : November 2012